Both in Pharmaceuticals
Braveheart Bio vs Sarepta Therapeutics,
Over the past year BRVE returned −19.4% and SRPT returned −6.9%; their daily moves had a correlation of 0.13.
BRVE −19.4% SRPT −6.9%Growth of $1, one year, split-adjusted
| Metric | BRVE | SRPT |
|---|---|---|
| Price | $21.47 | $19.04 |
| Market cap | $1.93B | $2.01B |
| Today | −1.63% | +0.79% |
| 1 month | −3.9% | +2.1% |
| 6 months | — | −7.9% |
| Year to date | — | −11.5% |
| 1 year | — | −19.0% |
| Revenue growth (YoY) | — | −34.3% |
| Gross margin | — | 62.8% |
| Net margin | — | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.0× |
| Net cash | — | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 63.2% |
| Short % of float | 10.9% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).